
    
      Long Term Follow-up for the Detection of Delayed Adverse Events in Recipients of CD4+ T
      Lymphocytes and/or CD34+ Hematopoietic Stem/Progenitor Cells Transduced with LVsh5/C46
      (Cal-1), a Dual Anti-HIV Gene Transfer Construct
    
  